US 12,295,917 B2
Drug delivery device having controlled delivery and confirmation
Noel C. Codella, Yorktown Heights, NY (US); Jonathan H. Connell, II, Cortlandt-Manor, NY (US); Sharathchandra Pankanti, Darien, CT (US); and Nalini K. Ratha, Yorktown Heights, NY (US)
Assigned to International Business Machines Corporation, Armonk, NY (US)
Filed by International Business Machines Corporation, Armonk, NY (US)
Filed on Jun. 29, 2021, as Appl. No. 17/361,535.
Application 17/361,535 is a continuation of application No. 15/848,169, filed on Dec. 20, 2017, granted, now 11,052,023.
Prior Publication US 2021/0322273 A1, Oct. 21, 2021
Int. Cl. A61J 3/07 (2006.01); A61B 5/00 (2006.01); A61B 5/07 (2006.01); A61B 5/145 (2006.01); A61K 9/20 (2006.01); A61K 9/48 (2006.01); G16H 10/60 (2018.01); G16H 20/10 (2018.01); A61M 31/00 (2006.01); G16H 10/20 (2018.01)
CPC A61J 3/07 (2013.01) [A61B 5/073 (2013.01); A61B 5/14507 (2013.01); A61B 5/14539 (2013.01); A61B 5/6861 (2013.01); A61B 5/6873 (2013.01); A61K 9/2072 (2013.01); A61K 9/4808 (2013.01); G16H 10/60 (2018.01); G16H 20/10 (2018.01); A61B 5/07 (2013.01); A61B 5/4833 (2013.01); A61B 5/6885 (2013.01); A61B 2503/08 (2013.01); A61B 2505/07 (2013.01); A61M 31/002 (2013.01); G16H 10/20 (2018.01)] 5 Claims
OG exemplary drawing
 
1. A method of controlling drug delivery devices, each drug delivery device comprising a capsule, a logic circuit disposed within the capsule, and an actuator connected to the logic circuit, the method comprising:
sensing a location of a first drug delivery device;
determining entry of the first drug delivery device into an intestine using the location;
communicating, by the first drug delivery device, an authorization request seeking permission to activate the actuator to an external computer system upon determining entry of the first drug delivery device into the intestine;
receiving, by the first drug delivery device, an authorization from the external computer system; and
activating, by the logic circuit of the first drug delivery device, the actuator of the first drug delivery device to expose an interior of the capsule of the first drug delivery device to an exterior of the capsule in response to receipt of the authorization.